个人中心
登出
中文简体
返回
-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
登录后咨询在线客服
回到顶部
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
12只医疗保健类股周四盘中走势
Gainers
- Midatech Pharma (NASDAQ:MTP) stock rose 36.76% to $2.79 during Thursday's regular session. Midatech Pharma's stock is trading at a volume of 69.8 million shares as of 12:32 EST. This is 29396.21% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $35.3 million.
- Cellect Biotechnology (NASDAQ:APOP) shares moved upwards by 27.54% to $4.17. Trading volume for Cellect Biotechnology's stock is 66.4 million as of 12:32 EST. This is 3188.53% of its average full-day volume over the last 100 days. The company's market cap stands at $16.3 million.
- Synaptogenix (NASDAQ:SNPX) shares increased by 26.4% to $11.25. As of 12:32 EST, this security is trading at a volume of 3.7 million shares, making up 1136.82% of its average full-day volume over the last 100 days. The company's market cap stands at $39.4 million.
- Capricor Therapeutics (NASDAQ:CAPR) stock increased by 16.13% to $5.11. The current volume of 2.8 million shares is 677.6% of Capricor Therapeutics's average full-day volume over the last 100 days (last updated at 12:32 EST). The market value of their outstanding shares is at $116.9 million.
- Clearside Biomedical (NASDAQ:CLSD) shares moved upwards by 14.7% to $4.68. Trading volume for Clearside Biomedical's stock is 37.3 million as of 12:32 EST. This is 2228.18% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $269.4 million.
- Rezolute (NASDAQ:RZLT) shares rose 14.16% to $12.65. Trading volume for Rezolute's stock is 38.0K as of 12:32 EST. This is 61.05% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $105.6 million.
Losers
- Novan (NASDAQ:NOVN) stock decreased by 20.91% to $10.96 during Thursday's regular session. Trading volume for this security as of 12:32 EST is 5.4 million, which is 76.35% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $166.1 million.
- Prothena Corp (NASDAQ:PRTA) shares fell 18.06% to $47.24. As of 12:32 EST, this security is trading at a volume of 505.7K shares, making up 119.48% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.0 billion.
- Opthea (NASDAQ:OPT) stock fell 15.71% to $8.72. As of 12:32 EST, this security is trading at a volume of 266.4K shares, making up 298.22% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $368.2 million.
- Predictive Oncology (NASDAQ:POAI) shares decreased by 10.73% to $1.0. Trading volume for Predictive Oncology's stock is 8.9 million as of 12:32 EST. This is 344.59% of its average full-day volume over the last 100 days. The company's market cap stands at $49.8 million.
- GBS (NASDAQ:GBS) shares fell 10.45% to $4.46. Trading volume for GBS's stock is 476.8K as of 12:32 EST. This is 90.83% of its average full-day volume over the last 100 days.
- Aprea Therapeutics (NASDAQ:APRE) stock fell 9.67% to $4.86. The current volume of 3.4 million shares is 120.18% of Aprea Therapeutics's average full-day volume over the last 100 days (last updated at 12:32 EST). The market value of their outstanding shares is at $102.9 million.
Gainers
赢家
- Midatech Pharma (NASDAQ:MTP) stock rose 36.76% to $2.79 during Thursday's regular session. Midatech Pharma's stock is trading at a volume of 69.8 million shares as of 12:32 EST. This is 29396.21% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $35.3 million.
- Cellect Biotechnology (NASDAQ:APOP) shares moved upwards by 27.54% to $4.17. Trading volume for Cellect Biotechnology's stock is 66.4 million as of 12:32 EST. This is 3188.53% of its average full-day volume over the last 100 days. The company's market cap stands at $16.3 million.
- Synaptogenix (NASDAQ:SNPX) shares increased by 26.4% to $11.25. As of 12:32 EST, this security is trading at a volume of 3.7 million shares, making up 1136.82% of its average full-day volume over the last 100 days. The company's market cap stands at $39.4 million.
- Capricor Therapeutics (NASDAQ:CAPR) stock increased by 16.13% to $5.11. The current volume of 2.8 million shares is 677.6% of Capricor Therapeutics's average full-day volume over the last 100 days (last updated at 12:32 EST). The market value of their outstanding shares is at $116.9 million.
- Clearside Biomedical (NASDAQ:CLSD) shares moved upwards by 14.7% to $4.68. Trading volume for Clearside Biomedical's stock is 37.3 million as of 12:32 EST. This is 2228.18% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $269.4 million.
- Rezolute (NASDAQ:RZLT) shares rose 14.16% to $12.65. Trading volume for Rezolute's stock is 38.0K as of 12:32 EST. This is 61.05% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $105.6 million.
- Midatech Pharma在周四的例会上,纳斯达克(Sequoia Capital:MTP)股价上涨36.76%,至2.79美元。截至美国东部时间12:32,Midatech Pharma的股票交易量为6,980万股。这是过去100日平均全天成交量的29396.21%。他们流通股的市值为3530万美元。
- Cellect生物技术(纳斯达克:APOP)股价上涨27.54%,至4.17美元。截至美国东部时间12:32,Cellect Biotech的股票成交量为6,640万股。这是过去100日平均全天成交量的3188.53%。该公司的市值为1,630万美元。
- 突触基因纳斯达克(SNPX:SNPX)股价上涨26.4%,至11.25美元。截至美国东部时间12:32,该证券成交量为370万股,占其过去100日全天平均成交量的1136.82。该公司的市值为3940万美元。
- 卡布里卡治疗公司纳斯达克(Sequoia Capital:CAPR)股价上涨16.13%,至5.11美元。目前280万股的成交量是Capricor Treateutics过去100日全天平均成交量的677.6%(最近一次更新是在美国东部时间12:32)。他们流通股的市值为1.169亿美元。
- Clearside Biomedical纳斯达克(Sequoia Capital:CLSD)股价上涨14.7%至4.68美元。截至美国东部时间12:32,Clearside Biomedical的股票成交量为3,730万股。这是过去100日平均全天成交量的2228.18%。他们流通股的市值为2.694亿美元。
- 重沸剂纳斯达克(Tmall:RZLT)股价上涨14.16%,至12.65美元。截至美国东部时间12:32,Rezolute股票的成交量为38.0K。这是过去100天全天平均成交量的61.05%。他们流通股的市值为1.056亿美元。
Losers
失败者
- Novan (NASDAQ:NOVN) stock decreased by 20.91% to $10.96 during Thursday's regular session. Trading volume for this security as of 12:32 EST is 5.4 million, which is 76.35% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $166.1 million.
- Prothena Corp (NASDAQ:PRTA) shares fell 18.06% to $47.24. As of 12:32 EST, this security is trading at a volume of 505.7K shares, making up 119.48% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.0 billion.
- Opthea (NASDAQ:OPT) stock fell 15.71% to $8.72. As of 12:32 EST, this security is trading at a volume of 266.4K shares, making up 298.22% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $368.2 million.
- Predictive Oncology (NASDAQ:POAI) shares decreased by 10.73% to $1.0. Trading volume for Predictive Oncology's stock is 8.9 million as of 12:32 EST. This is 344.59% of its average full-day volume over the last 100 days. The company's market cap stands at $49.8 million.
- GBS (NASDAQ:GBS) shares fell 10.45% to $4.46. Trading volume for GBS's stock is 476.8K as of 12:32 EST. This is 90.83% of its average full-day volume over the last 100 days.
- Aprea Therapeutics (NASDAQ:APRE) stock fell 9.67% to $4.86. The current volume of 3.4 million shares is 120.18% of Aprea Therapeutics's average full-day volume over the last 100 days (last updated at 12:32 EST). The market value of their outstanding shares is at $102.9 million.
- Novan纳斯达克(Sequoia Capital:NOVN)股价周四例会下跌20.91%,至10.96美元。截至美国东部时间12:32,该证券的成交量为540万,是过去100天全天平均成交量的76.35%。他们流通股的市值为1.661亿美元。
- 普罗塞纳公司纳斯达克(Tmall:PRTA)股价下跌18.06%,至47.24美元。截至美国东部时间12:32,该证券成交量为505.7K股,占其过去100日全天平均成交量的119.48。他们流通股的市值为20亿美元。
- 奥普西娅(纳斯达克代码:OPT)股价下跌15.71%,至8.72美元。截至美国东部时间12:32,该证券成交量为266.4K股,占其过去100日全天平均成交量的298.22。他们流通股的市值为3.682亿美元。
- 预测肿瘤学纳斯达克(Tmall:POAI)股价下跌10.73%,至1.0美元。截至美国东部时间12:32,Predictive Oncology的股票成交量为890万股。这是过去100日平均全天成交量的344.59%。该公司的市值为4980万美元。
- GBS纳斯达克(Standard Chartered Bank:GBS)股价下跌10.45%,至4.46美元。截至美国东部时间12:32,GBS股票成交量为476.8K。这是过去100天全天平均成交量的90.83%。
- Aprea治疗公司(纳斯达克代码:APRE)股价下跌9.67%,至4.86美元。目前340万股的成交量是Aprea Treateutics过去100日平均全天成交量的120.18%(最近一次更新是在美国东部时间12:32)。他们流通股的市值为1.029亿美元。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
抢沙发
0 0 0
赞大爱笑哭社会社会Emm心碎怒
轻触选择心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧
点击这里分享给好友
暂无评论,快来抢沙发吧!